Shanxi C&Y Pharmaceutical Group Co Ltd Market Cap ($283.41 Million)

$283.41 Million USD  · CN¥1.94 Billion CNY  · Rank #14833

Market Cap & Net Worth: Shanxi C&Y Pharmaceutical Group Co Ltd (300254)

Shanxi C&Y Pharmaceutical Group Co Ltd market cap. Shanxi C&Y Pharmaceutical Group Co Ltd (SHE:300254) has a market capitalization of $283.41 Million (CN¥1.94 Billion) as of November 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #14833 globally and #4355 in its home market, demonstrating a -1.95% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanxi C&Y Pharmaceutical Group Co Ltd's stock price CN¥7.53 by its total outstanding shares 257208563 (257.21 Million). Also see cash efficiency ratio of Shanxi C&Y Pharmaceutical Group Co Ltd for how efficiently the company converts equity into cash flow.

Shanxi C&Y Pharmaceutical Group Co Ltd Market Cap History (2015–2026)

Shanxi C&Y Pharmaceutical Group Co Ltd market cap history from 2015 to 2026. Data shows change from $1.09 Billion to $283.41 Million (-10.31% CAGR). Check Shanxi C&Y Pharmaceutical Group Co Ltd (300254) share price today for real-time trading data and today's change.

Shanxi C&Y Pharmaceutical Group Co Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Shanxi C&Y Pharmaceutical Group Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Shanxi C&Y Pharmaceutical Group Co Ltd to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

0.44x

Shanxi C&Y Pharmaceutical Group Co Ltd's market cap is 0.44 times its annual revenue

Industry average: 0.59x Lower than industry average

Latest Price to Earnings (P/E) Ratio

15.33x

Shanxi C&Y Pharmaceutical Group Co Ltd's market cap is 15.33 times its annual earnings

Industry average: 13.94x Higher than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2016 $717.38 Million $746.08 Million $30.15 Million 0.96x 23.80x
2017 $384.82 Million $938.93 Million $21.67 Million 0.41x 17.76x
2018 $243.26 Million $1.14 Billion $7.24 Million 0.21x 33.59x
2019 $305.24 Million $1.13 Billion $5.30 Million 0.27x 57.63x
2020 $259.32 Million $848.07 Million -$262.37 Million 0.31x N/A
2021 $327.07 Million $930.37 Million -$91.44 Million 0.35x N/A
2022 $254.81 Million $829.00 Million -$118.52 Million 0.31x N/A
2023 $362.45 Million $799.31 Million $25.20 Million 0.45x 14.39x
2024 $329.33 Million $846.61 Million $42.19 Million 0.39x 7.81x
2025 $380.89 Million $870.79 Million $24.85 Million 0.44x 15.33x

Competitor Companies of 300254 by Market Capitalization

Companies near Shanxi C&Y Pharmaceutical Group Co Ltd in the global market cap rankings as of November 5, 2026. Also see Shanxi C&Y Pharmaceutical Group Co Ltd (300254) total assets for a full breakdown of the balance sheet.

Key companies related to Shanxi C&Y Pharmaceutical Group Co Ltd by market ranking:

  • Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #514 globally with a market cap of $52.60 Billion USD.
  • GALDERMA GROUP AG (NYSE:GALDY): Ranked #538 globally with a market cap of $50.42 Billion USD.
  • Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #588 globally with a market cap of $45.79 Billion USD ( CN¥312.89 Billion CNY).
  • Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #621 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#514 Takeda Pharmaceutical Co Ltd ADR NYSE:TAK $52.60 Billion $16.65
#538 GALDERMA GROUP AG NYSE:GALDY $50.42 Billion $47.80
#588 Jiangsu Hengrui Medicine Co Ltd SHG:600276 $45.79 Billion CN¥49.05
#621 Takeda Pharmaceutical Company Limited F:TKDA $43.60 Billion €18.50

Market Capitalization of Shanxi C&Y Pharmaceutical Group Co Ltd (2015–2026)

Market capitalization of Shanxi C&Y Pharmaceutical Group Co Ltd from 2015 to today. Between 2015 and today, Shanxi C&Y Pharmaceutical Group Co Ltd's market cap moved from $1.09 Billion to $ 283.41 Million, with a yearly change of -10.31%.

Year Market Cap Change (%)
2026 CN¥283.41 Million -25.59%
2025 CN¥380.89 Million +15.66%
2024 CN¥329.33 Million -9.14%
2023 CN¥362.45 Million +42.25%
2022 CN¥254.81 Million -22.09%
2021 CN¥327.07 Million +26.12%
2020 CN¥259.32 Million -15.04%
2019 CN¥305.24 Million +25.48%
2018 CN¥243.26 Million -36.79%
2017 CN¥384.82 Million -46.36%
2016 CN¥717.38 Million -34.12%
2015 CN¥1.09 Billion --

End of Day Market Cap According to Different Sources

On Nov 5th, 2026 the market cap of Shanxi C&Y Pharmaceutical Group Co Ltd was reported to be:

Source Market Cap
Yahoo Finance $283.41 Million USD
MoneyControl $283.41 Million USD
MarketWatch $283.41 Million USD
marketcap.company $283.41 Million USD
Reuters $283.41 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Shanxi C&Y Pharmaceutical Group Co Ltd

SHE:300254 China Drug Manufacturers - Specialty & Generic
Market Cap
$283.41 Million
CN¥1.94 Billion CNY
Market Cap Rank
#14833 Global
#4355 in China
Share Price
CN¥7.53
Change (1 day)
+2.59%
52-Week Range
CN¥7.27 - CN¥14.68
All Time High
CN¥31.09
About

ShanXi C&Y Pharmaceutical Group Co.,LTD. engages in the research, development, production, and sale of medicine and health food products. It provides anti-infective drugs, anti-allergic drugs, smoking cessation drugs, pediatric drugs, respiratory system drugs, urinary system drugs, kidney disease drugs, children's drugs, cardiovascular and cerebrovascular drugs, nephropathy drugs, anti-depressant… Read more